Funded Tech Companies
NanoSyrinx
Wondering who backed NanoSyrinx? Eli Lilly and Company, Meltwind Advisory and Octopus Ventures joined the equity holders in this innovative life sciences company.
Company Overview
Company Name
NanoSyrinx
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
The Venture Centre, University of Warwick Science Park
Coventry, CV47EZ
UK
Coventry, CV47EZ
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Many therapeutics need access to the interiors of cells, where the machinery of life is busy going about its tasks. Historically, reaching the interior of cells with therapeutic molecules has been a recalcitrant problem. NanoSyrinx is a discovery stage synthetic biology company developing a novel system based around naturally occurring 'nanosyringes', to overcome this challenge by delivering therapeutic proteins and peptides direct to the cytosol in a targeted manner.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/10/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Edwin Moses
Chief Executive Officer
Joseph Healey
Chief Scientific Officer
Marie McAvoy
VP - Bus. Development
James Lapworth
Company Investors
- Eli Lilly and Company
- Meltwind Advisory
- Octopus Ventures
- M Ventures
- BGF Ventures
- IQ Capital Fund
Browse more funded tech companies:
NanoString Technologies | Nanosys
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs